Primary human papillomavirus testing in organized cervical screening

Current Opinion in Obstetrics and Gynecology

Volumn 25, Issue 1, 2013, Pages 11-16

  Dillner, Joakim ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cervical cancer; prevention; purchasing; systematic review

Indexed keywords

CERVICAL SCREENING; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH CARE POLICY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING TEST; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

CYTODIAGNOSIS; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84872845690     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32835c5d10     Document Type: Review

References (10)

1. Ronco G, Biggeri A, Confortini M, et al. Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors. Epidemiol Prev 2012; 36 (3-4 Suppl. 1):e1-e72.
2. De Kok IM, van Rosmalen J, Dillner J, et al. Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model. BMJ 2012; 344:e670; doi: 10.1136/bmj.e670.
3. Arbyn M, Andersson K, Bergeron C, et al. Cervical cytology biobanks as a resource for molecular epidemiology. Methods Mol Biol 2011; 675:279-298.
4. Dillner J, Andersson K. Biobanks collected for routine healthcare purposes: build-up and use for epidemiologic research. Methods Mol Biol 2011; 675:113-125.
5. Eklund C, Forslund O, Wallin KL, et al., WHO Human Papillomavirus Laboratory Network. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol 2012; 50:2289-2298; doi: 10.1128/JCM.00840-12.
6. Hakama M, Malila N, Dillner J. Randomised health services studies. Int J Cancer 2012; 131:2898-2902; doi: 10.1002/ijc.27561.
7. Söderlund-Strand A, Eklund C, Kemetli L, et al. Genotyping of human papillomavirus in triaging of low-grade cervical cytology. Am J Obstet Gynecol 2011; 205:145e1-145e6.
8. Andrae B, Andersson TM, Lambert PC, et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012; 344:e900; doi: 10.1136/bmj.e900.
9. Lö nnberg S, Nieminen P, Luostarinen T, Anttila A. Mortality audit of the Finnish cervical cancer screening program. Int J Cancer 2012. doi: 10.1002/ijc.27844 [Epub ahead of print].
10. Silfverdal L, Kemetli L, Sparén P, et al. Risk of invasive cervical cancer in relation to clinical investigation and treatment after abnormal cytology: a population-based case-control study. Int J Cancer 2011; 129:1450-1458; doi: 10.1002/ijc.25749.